000 | 01943 a2200541 4500 | ||
---|---|---|---|
005 | 20250518031315.0 | ||
264 | 0 | _c20190604 | |
008 | 201906s 0 0 eng d | ||
022 | _a1476-5586 | ||
024 | 7 |
_a10.1016/j.neo.2019.02.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLee, Rachel S | |
245 | 0 | 0 |
_aCharacterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target. _h[electronic resource] |
260 |
_bNeoplasia (New York, N.Y.) _c04 2019 |
||
300 |
_a389-400 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aBiomarkers, Tumor |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aGene Knockdown Techniques |
650 | 0 | 4 | _aGerminal Center Kinases |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
650 | 0 | 4 |
_aTranscriptional Regulator ERG _xmetabolism |
700 | 1 | _aZhang, Luxi | |
700 | 1 | _aBerger, Adeline | |
700 | 1 | _aLawrence, Mitchell G | |
700 | 1 | _aSong, Jiangning | |
700 | 1 | _aNiranjan, Birunthi | |
700 | 1 | _aDavies, Rebecca G | |
700 | 1 | _aLister, Natalie L | |
700 | 1 | _aSandhu, Shahneen K | |
700 | 1 | _aRubin, Mark A | |
700 | 1 | _aRisbridger, Gail P | |
700 | 1 | _aTaylor, Renea A | |
700 | 1 | _aRickman, David S | |
700 | 1 | _aHorvath, Lisa G | |
700 | 1 | _aDaly, Roger J | |
773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 21 _gno. 4 _gp. 389-400 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neo.2019.02.005 _zAvailable from publisher's website |
999 |
_c29507148 _d29507148 |